Related Experiment Videos
Coexistent Anaplastic and Differentiated Thyroid Carcinoma.
Yatsuki Aratake1, Hajime Nomura, Tomio Kotani
1Central Laboratory for Clinical Investigation, Miyazaki University Hospital, Miyazaki, Japan.
American Journal of Clinical Pathology
|April 15, 2006
Summary
Anaplastic thyroid carcinoma (ATC) shows aggressive behavior due to molecular changes. Undifferentiated ATC cells exhibit high proliferation, suppressed apoptosis, and disrupted cell interactions, impacting prognosis.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Anaplastic thyroid carcinoma (ATC) is an aggressive malignancy with poor prognosis.
- Understanding the molecular drivers of ATC's aggressive behavior is crucial for improved diagnostics and therapeutics.
Purpose of the Study:
- To identify key molecules associated with the aggressive behavior of undifferentiated anaplastic thyroid carcinoma.
- To compare molecular differences between undifferentiated and differentiated areas within ATC tumors.
Main Methods:
- Immunohistochemical analysis of 5 ATC cases with differentiated areas.
- Evaluation of markers including Ki-67, PCNA, p53, Apaf-1, CD26, galectin-3, E-cadherin, and CD147.
Main Results:
- Increased proliferation markers (Ki-67, PCNA) and p53 in undifferentiated areas.
- Decreased apoptosis regulator (Apaf-1) and cell adhesion molecules (CD26, galectin-3, E-cadherin) in undifferentiated areas.
- Overexpression of CD147, potentially inducing matrix metalloproteinases, in undifferentiated areas.
Conclusions:
- Undifferentiated ATC exhibits high proliferation, suppressed apoptosis, and disrupted cell-cell interactions.
- The studied molecules are potential biomarkers for assessing ATC aggressiveness and patient prognosis.